Avior Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$767K Buy
1,461
+581
+66% +$305K 0.03% 338
2025
Q1
$558K Sell
880
-310
-26% -$197K 0.02% 374
2024
Q4
$848K Buy
1,190
+268
+29% +$191K 0.03% 316
2024
Q3
$969K Buy
922
+1
+0.1% +$1.05K 0.04% 296
2024
Q2
$968K Sell
921
-65
-7% -$68.3K 0.04% 277
2024
Q1
$949K Sell
986
-42
-4% -$40.4K 0.04% 299
2023
Q4
$903K Hold
1,028
0.05% 227
2023
Q3
$846K Buy
1,028
+4
+0.4% +$3.29K 0.06% 220
2023
Q2
$736K Hold
1,024
0.05% 254
2023
Q1
$841K Hold
1,024
0.06% 225
2022
Q4
$739K Sell
1,024
-217
-17% -$157K 0.06% 227
2022
Q3
$854K Hold
1,241
0.07% 188
2022
Q2
$732K Sell
1,241
-375
-23% -$221K 0.07% 193
2022
Q1
$1.13M Sell
1,616
-302
-16% -$211K 0.1% 146
2021
Q4
$1.21M Hold
1,918
0.1% 160
2021
Q3
$1.16M Hold
1,918
0.1% 158
2021
Q2
$1.07M Sell
1,918
-249
-11% -$139K 0.11% 167
2021
Q1
$1.03M Sell
2,167
-44
-2% -$20.8K 0.11% 171
2020
Q4
$1.07M Sell
2,211
-102
-4% -$49.2K 0.13% 146
2020
Q3
$1.29M Buy
2,313
+257
+13% +$144K 0.18% 119
2020
Q2
$1.28M Sell
2,056
-93
-4% -$57.9K 0.2% 119
2020
Q1
$1.05M Buy
2,149
+29
+1% +$14.1K 0.21% 119
2019
Q4
$795K Hold
2,120
0.13% 164
2019
Q3
$587K Buy
2,120
+132
+7% +$36.5K 0.1% 188
2019
Q2
$622K Buy
1,988
+72
+4% +$22.5K 0.11% 175
2019
Q1
$786K Hold
1,916
0.17% 129
2018
Q4
$715K Hold
1,916
0.17% 124
2018
Q3
$774K Hold
1,916
0.17% 124
2018
Q2
$661K Buy
1,916
+202
+12% +$69.7K 0.15% 136
2018
Q1
$590K Buy
1,714
+119
+7% +$41K 0.14% 149
2017
Q4
$600K Buy
1,595
+1,570
+6,280% +$591K 0.13% 147
2017
Q3
$11K Hold
25
﹤0.01% 328
2017
Q2
$12K Hold
25
﹤0.01% 297
2017
Q1
$10K Buy
+25
New +$10K ﹤0.01% 351